Merlin wins award

Merlin Biosciences has won the GP Capital Investor Allstars award for ‘Venture Capital Fund of the Year.’ The award was given to Merlin in recognition of its outstanding commitment in the life sciences sector across Europe. The criteria included a track record for innovative fund raising, quality of investments and exits, a reputation for adding value to portfolio companies, not just finance and a reputation for working closely with the early stage investment community.